Ucb Pharma, S.a.

Ucb Biopharma Sprl

Ucbbiopharma Srl

Karen Margrete Miller

Alastair David Griffiths Lawson

Terence Seward Baker

Helene Margaret Finney

Marc Roger De Ryck

Christian Gilbert J Wolff

Alastair David Lawson

Christian Gilbert Wolff

A Na1.7 binding entity that after binding functionally modifies the activity of the ion channel, in particular an anti-Na1.7 antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.

[object Object]

An anti-E1 ion channel antibody or binding fragment thereof, pharmaceutical compositions comprising said antibodies, use of the antibodies and compositions comprising the same, in treatment, for example in the treatment/modulation of pain and processes for generating and preparing said antibodies.

Method of treating a patient for pain by administering an anti-ion channel antibody

Antibodies to the E1 extracellular loop of ion channels

Function modifying NAv 1.7 antibodies

Growing community of inventors

Brussels, Belgium

Karen Margrete Miller